Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
High steady-state column density of I((2)P3/2) atoms from I2 photodissociation at 532 nm: Towards parity non-conservation measurements.

Scientific reports

Katsoprinakis GE, Chatzidrosos G, Kypriotakis JA, Stratakis E, Rakitzis TP.
PMID: 27629914
Sci Rep. 2016 Sep 15;6:33261. doi: 10.1038/srep33261.

Steady-state column densities of 10(17) cm(-2) of I((2)P3/2) atoms are produced from photodissociation of I2 vapour at 290.5 K using 5 W of 532 nm laser light. Recombination of the I((2)P3/2) atoms at the cell walls is minimized by...

The Effects of the Factors Related to the Patient and the Disease on the Performance of Ablation Therapy in Patients with Differentiated Thyroid Cancer who have Received I-131 Ablation Therapy.

Molecular imaging and radionuclide therapy

Sengöz T, Sürücü E, Demir Y, Derebek E.
PMID: 23487510
Mol Imaging Radionucl Ther. 2012 Dec;21(3):103-9. doi: 10.4274/Mirt.25744. Epub 2012 Dec 20.

OBJECTIVE: To investigate whether the factors related to the patient and the disease have any effect on the success of ablation therapy in patients with differentiated thyroid cancer who have received I-131 ablation therapy.MATERIAL AND METHODS: All the patients...

Effectiveness of Fixed Dose Radioactive Iodine (RAI) for the Treatment of Hyperthyroidism: Experience of a Teaching Hospital in South West Nigeria.

Molecular imaging and radionuclide therapy

Enyi Ejeh M J, Omotayo Ogunjobi K, Enyi Ejeh J, Solomon Adedapo K, F Eniojukan J.
PMID: 24003395
Mol Imaging Radionucl Ther. 2013 Aug;22(2):36-41. doi: 10.4274/Mirt.08370. Epub 2013 Aug 01.

OBJECTIVE: Using radioactive iodine (RAI) as the first line therapy for Graves' hyperthyroidism and as the treatment of choice for relapsed Graves' disease is increasing in recent times. However, there has been little consensus on the most appropriate dose...

Intravenous contrast use and acute kidney injury: a retrospective study of 1,238 inpatients undergoing computed tomography.

Radiologia brasileira

Coser TA, Leitão JSV, Beltrame BM, Selistre LS, Tasso L.
PMID: 33854260
Radiol Bras. 2021 Mar-Apr;54(2):77-82. doi: 10.1590/0100-3984.2020.0018.

OBJECTIVE: To determine the incidence of nephropathy induced by intravenous contrast in hospitalized patients undergoing computed tomography (CT).MATERIALS AND METHODS: This was a retrospective cohort study involving 1,238 patients who underwent CT with or without intravenous administration of a...

Second malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131.

Clujul medical (1957)

Piciu D, Pestean C, Barbus E, Larg MI, Piciu A.
PMID: 27547058
Clujul Med. 2016;89(3):384-9. doi: 10.15386/cjmed-636. Epub 2016 Jul 28.

BACKGROUND AND AIM: This study aimed at determining whether there is a risk regarding the development of second primary malignancies after patient exposure to the low and medium radioiodine activity used during the treatment of differentiated thyroid cancers (DTC).METHODS:...

Binding and Internalization of Iron Oxide Nanoparticles Targeted to Nuclear Oncoprotein.

Journal of molecular biomarkers & diagnosis

Knight LC, Romano JE, Krynska B, Faro S, Mohamed FB, Gordon J.
PMID: 23487404
J Mol Biomark Diagn. 2010;1(1). doi: 10.4172/2155-9929.1000102.

A targeted nanoconjugate is being developed for non-invasive detection of gene expression in cells expressing the JC virus oncoprotein, T-antigen, which has been associated with medulloblastoma and other cancers. JC virus T-antigen localizes predominantly to the nucleus via a...

Capture of Iodine from Nuclear-Fuel-Reprocessing Off-Gas: Influence of Aging on a Reduced Silver Mordenite Adsorbent after Exposure to NO/NO.

ACS applied materials & interfaces

Wiechert AI, Ladshaw AP, Moon J, Abney CW, Nan Y, Choi S, Liu J, Tavlarides LL, Tsouris C, Yiacoumi S.
PMID: 33090761
ACS Appl Mater Interfaces. 2020 Nov 04;12(44):49680-49693. doi: 10.1021/acsami.0c15456. Epub 2020 Oct 22.

Iodine radioisotopes released during nuclear fuel reprocessing must be removed from the off-gas stream before discharge. One promising material for iodine capture is reduced silver mordenite (Ag

Psychological impact of .

Clujul medical (1957)

Barbus E, Pestean C, Larg MI, Gabora K, Bonci EA, Badulescu C, Piciu A.
PMID: 30564021
Clujul Med. 2018 Oct;91(4):441-447. doi: 10.15386/cjmed-1042. Epub 2018 Oct 30.

BACKGROUND AND AIMS: It is very well know nowadays that despite all the good and qualitative information available, the patients who are supposed to be treated with radioiodine for differentiated thyroid cancer suffer from a lot of concerns prior...

Differences between radioactive iodine-induced sialadenitis and chronic obstructive parotitis.

International journal of oral and maxillofacial surgery

Li X, Zhao YN, Zhang LQ, Su JZ, Liu DG, Yu GY.
PMID: 34776313
Int J Oral Maxillofac Surg. 2021 Nov 11; doi: 10.1016/j.ijom.2021.11.003. Epub 2021 Nov 11.

The purpose of this study was to clarify the differences in the diagnosis and treatment outcomes between radioactive iodine-induced sialadenitis (RAIS) and chronic obstructive parotitis (COP). The study cohort comprised 47 consecutive patients diagnosed with RAIS and 50 patients...

Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer.

Oral oncology

Boucher A, Ezzat S, Hotte S, Rachinsky I, Rajaraman M, Ruether D, Wiseman SM, Brierley J, Ho C, Krzyzanowska M, Lamond N, Massicotte MH, Joseph S, Herscovitch K, Sikora L, Winquist E.
PMID: 34388408
Oral Oncol. 2021 Oct;121:105477. doi: 10.1016/j.oraloncology.2021.105477. Epub 2021 Aug 10.

Radioactive iodine-resistant differentiated thyroid cancer (RAIRTC) is an aggressive form of thyroid cancer that is uncommon and heterogeneous in its clinical behavior. With the emergence of more effective systemic therapy, the need for guidance in decision-making was recognized and...

Myopathy following postoperative ablative radioiodine for follicular carcinoma of the thyroid.

International medical case reports journal

Price HC, Jayagopal V.
PMID: 23754875
Int Med Case Rep J. 2009 Mar 19;2:11-3. doi: 10.2147/imcrj.s5254. Print 2009.

We highlight a case of disabling myopathy following radioablative iodine treatment for follicular carcinoma of the thyroid. A 34-year-old man presented with a tender neck swelling, ultrasound and biopsy were suggestive of thyroid malignancy. Thyroidectomy was undertaken and histology...

Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients.

Journal of clinical and diagnostic research : JCDR

Badam RK, Suram J, Babu DB, Waghray S, Marshal R, Bontha SC, Lavanya R, Kanth S.
PMID: 26894178
J Clin Diagn Res. 2016 Jan;10(1):ZC60-2. doi: 10.7860/JCDR/2016/16091.7121. Epub 2016 Jan 01.

INTRODUCTION: Thyroid carcinoma represents less than 1% of all cancers. The first line of treatment for thyroid cancer is partial/total thyroidectomy. High-dose Iodine(131) therapy using Iodine radioisotopes is commonly used in patients with well differentiated thyroid carcinoma after total...

Showing 1 to 12 of 22 entries